Currently detected predominantly using an expensive enzymatic immunoassay (i.e., ELISA test) [30], lysozyme (LYZ) and interleukin-8 (IL-8) have already been shown to be differentially expressed in several disease states of head and neck cancer or infections. This evidence concerns the gene CXCL8 and head and neck cancer.